Profound Medical Corp. 8-K

What Happened

• On April 1, 2026, Profound Medical Corp. filed a Form 8-K (Item 7.01) disclosing that its interventional MRI TULSA Procedure™ will be featured in multiple presentations at the 2026 Society of Interventional Radiology (SIR) Annual Scientific Meeting in Toronto, ON, scheduled for April 11–15, 2026. The company furnished a press release announcing this news as Exhibit 99.1 to the 8-K.

Key Details

• Filed date: April 1, 2026 (Form 8-K, Item 7.01 — Regulation FD Disclosure).
• Event: 2026 SIR Annual Scientific Meeting, Toronto, April 11–15, 2026.
• Disclosure: Press release dated April 1, 2026 furnished as Exhibit 99.1.
• Signature: Report signed by Rashed Dewan, Chief Financial Officer, on behalf of Profound.

Why It Matters

• This is a non‑financial, public disclosure highlighting Profound’s TULSA technology in a major interventional radiology conference, which can increase clinical and professional visibility.
• The filing does not report earnings, management changes, or material financial developments; it informs investors and the market about upcoming presentations and related outreach.